Grants and Contributions:
Title:
Development of T Cell Immunoassay for COVID-19 and other diseases
Agreement Number:
964595
Agreement Value:
$50,000.00
Agreement Date:
Feb 1, 2021 - Aug 31, 2021
Description:
The project will involve the development of a diagnostic test to detect anti-SARS-CoV-2-specific T cells in a small sample of peripheral blood with initial aim to test vaccine effectiveness in terms of cell mediated immunity and understand which vaccine recipients are potentially immune to COVID-19 to triage vaccine prioritization in Canada.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V5Z 3Y1
Reference Number:
172-2020-2021-Q4-964595
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
705017879
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days. The total amended value is 10,000 dollars.
Amendment Date
May 19, 2021
Recipient's Legal Name:
Immunity Diagnostics Inc
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
6215
Amendments: